Crosstalk between bone marrow-derived mesenchymal stem cells and regulatory T cells through a glucocorticoid-induced leucine zipper/developmental endothelial locus-1-dependent mechanism

FASEB Journal

Volumn 29, Issue 9, 2015, Pages 3954-3963

  Yang, Nianlan ^a   Baban, Babak ^b   Isales, Carlos M ^a   Shi, Xing Ming ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

Bone loss; Bone marrow microenvironment; Immune suppressive

Indexed keywords

DEVELOPMENTAL ENDOTHELIAL LOCUS 1 PROTEIN; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NUCLEIC ACID BINDING PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CARRIER PROTEIN; DSIP1 PROTEIN, MOUSE; EDIL3 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE TISSUE; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; ANTIGEN PRESENTATION; BONE MARROW CELL; CYTOLOGY; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CARRIER PROTEINS; CELL COMMUNICATION; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84965083645     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-273664     Document Type: Article

References (37)

1. Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., and Riccardi, C. (2001) Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98, 743-753
2. Ayroldi, E., Zollo, O., Bastianelli, A., Marchetti, C., Agostini, M., Di Virgilio, R., and Riccardi, C. (2007) GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J. Clin. Invest. 117, 1605-1615
3. Yang, N., Zhang, W., and Shi, X. M. (2008) Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J. Cell. Biochem. 103,1760-1771
4. D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., and Riccardi, C. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7, 803-812
5. Riccardi, C., Cifone, M. G., and Migliorati, G. (1999) Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ. 6, 1182-1189
6. Berrebi, D., Bruscoli, S., Cohen, N., Foussat, A., Migliorati, G., Bouchet-Delbos, L., Maillot, M. C., Portier, A., Couderc, J., Galanaud, P., Peuchmaur, M., Riccardi, C., and Emilie, D. (2003) Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101,729-738
7. Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S., and Cao, X. (2003) A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374-380
8. Cohen, N., Mouly, E., Hamdi, H., Maillot, M. C., Pallardy, M., Godot, V.,Capel,F.,Balian,A.,Naveau,S.,Galanaud,P.,Lemoine,F.M.,and Emilie, D. (2006) GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107, 2037-2044
9. Choi,E.Y.,Chavakis,E.,Czabanka,M.A.,Langer,H.F.,Fraemohs, L., Economopoulou, M., Kundu, R. K., Orlandi, A., Zheng, Y. Y., Prieto, D. A., Ballantyne, C. M., Constant, S. L., Aird, W. C., Papayannopoulou, T., Gahmberg, C. G., Udey, M. C., Vajkoczy, P., Quertermous, T., Dimmeler, S., Weber, C., and Chavakis, T. (2008) Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101-1104
10. Choi, E. Y. (2009) Inhibition of leukocyte adhesion by developmental endothelial locus-1 (del-1). Immune Netw. 9, 153-157
11. Eskan, M. A., Jotwani, R., Abe, T., Chmelar, J., Lim, J. H., Liang, S., Ciero,P.A.,Krauss,J.L.,Li,F.,Rauner,M.,Hofbauer,L.C.,Choi, E. Y., Chung, K. J., Hashim, A., Curtis, M. A., Chavakis, T., and Hajishengallis, G. (2012) The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13, 465-473
12. Pan, G., Cao, J., Yang, N., Ding, K., Fan, C., Xiong, W.-C., Hamrick, M., Isales, C. M., and Shi, X.-M. (2014) Role of glucocorticoidinduced leucine zipper (GILZ) in bone acquisition. J. Biol. Chem. 289, 19373-19382
13. He, L., Yang, N., Isales, C. M., and Shi, X. M. (2012) Glucocorticoidinduced leucine zipper (GILZ) antagonizes TNF-a inhibition of mesenchymal stem cell osteogenic differentiation. PLoS ONE 7, e31717
14. Wan, Y. Y., and Flavell, R. A. (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126-5131
15. Zhao,E.,Wang,L.,Dai,J.,Kryczek,I.,Wei,S.,Vatan,L.,Altuwaijri,S., Sparwasser, T., Wang, G., Keller, E. T., and Zou, W. (2012) Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. OncoImmunology 1, 152-161
16. Zou, L., Barnett, B., Safah, H., Larussa, V. F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T. J., and Zou, W. (2004) Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64, 8451-8455
17. Ge, X., Bai, C., Yang, J., Lou, G., Li, Q., and Chen, R. (2013) Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4+CD25+ regulatory T cells in asthmatic mouse. Cell Biol. Int. 37, 675-686
18. Papadopoulou, A., Yiangou, M., Athanasiou, E., Zogas, N., Kaloyannidis, P., Batsis, I., Fassas, A., Anagnostopoulos, A., and Yannaki, E. (2012) Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann. Rheum. Dis. 71,1733-1740
19. Liu,Y.L.,Wang,Y.D.,Zhuang,F.,Xian,S.L.,Fang,J.Y.,Su,W.,and Zhang, W. (2012) Immunosuppression effects of bone marrow mesenchymal stem cells on renal interstitial injury in rats with unilateral ureteral obstruction. Cell. Immunol. 276, 144-152
20. Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A.,Santarlasci,V.,Mazzinghi,B.,Pizzolo,G.,Vinante,F.,Romagnani, P., Maggi, E., Romagnani, S., and Annunziato, F. (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24,386-398
21. Sato,K.,Ozaki,K.,Oh,I.,Meguro,A.,Hatanaka,K.,Nagai,T.,Muroi, K., andOzawa, K. (2007) Nitricoxide playsa critical roleinsuppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228-234
22. Wang, J., Wang, G., Sun, B., Li, H., Mu, L., Wang, Q., Li, G., Shi, L., Jin, L., and Kostulas, N. (2008) Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromalcelltreatment.J. Autoimmun. 30, 222-229
23. Nemeth, K., Keane-Myers, A., Brown, J. M., Metcalfe, D. D., Gorham, J. D., Bundoc, V. G., Hodges, M. G., Jelinek, I., Madala, S., Karpati, S., and Mezey, E. (2010) Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc.Natl.Acad.Sci.USA107,5652-5657
24. Zhang, W., Ou, G., Hamrick, M., Hill, W., Borke, J., Wenger, K., Chutkan, N., Yu, J., Mi, Q. S., Isales, C. M., and Shi, X. M. (2008) Agerelated changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J. Bone Miner. Res. 23, 1118-1128
25. Baban, B., Liu, J. Y., Abdelsayed, R., and Mozaffari, M. S. (2013) Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome. Exp. Mol. Pathol. 95, 288-297
26. Mozaffari, M. S., Baban, B., Abdelsayed, R., Liu, J. Y., Wimborne, H., Rodriguez, N., and Abebe, W. (2012) Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage. J. Nutr. Biochem. 23, 977-985
27. Zhang, W., Yang, N., and Shi, X. M. (2008) Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoidinduced leucine zipper (GILZ). J. Biol. Chem. 283,4723-4729
28. Chen,W.,Jin,W.,Hardegen,N.,Lei,K.J.,Li,L.,Marinos,N.,McGrady, G., and Wahl, S. M. (2003) Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886
29. Bettelli,E.,Carrier,Y.,Gao,W.,Korn,T.,Strom,T.B.,Oukka,M., Weiner,H.L.,andKuchroo,V.K.(2006)Reciprocaldevelopmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238
30. Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., and Neurath, M. F. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153
31. Oldenhove, G., Bouladoux, N., Wohlfert, E. A., Hall, J. A., Chou, D., Dos Santos, L., O'Brien, S., Blank, R., Lamb, E., Natarajan, S., Kastenmayer, R., Hunter, C., Grigg, M. E., and Belkaid, Y. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772-786
32. Cathelin, D., Met, Ö., and Svane, I. M. (2013) Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells. Cytotherapy 15, 740-749
33. Ciucurel, E. C., and Sefton, M. V. (2014) Del-1 overexpression in endothelial cells increases vascular density in tissue-engineered implants containing endothelial cells and adipose-derived mesenchymal stromal cells. Tissue Eng. Part A 20, 1235-1252
34. Ciucurel, E. C., Vlahos, A. E., and Sefton, M. V. (2014) Using Del-1 to tip the angiogenic balancein endothelial cells in modular constructs. Tissue Eng. Part A 20,1222-1234
35. Khader, S. A. (2012) Restraining IL-17: Del-1 deals the blow. Nat. Immunol. 13,433-435
36. Zhao, Y. F., Xiong, W., and Wu, X. L. (2014) Mesenchymal stem cellbased developmental endothelial locus-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. Mol. Med. Rep. 9, 1583-1589
37. Luz-Crawford, P., Tejedor, G., Mausset-Bonnefont, A. L., Beaulieu, E.,Morand,E.F.,Jorgensen,C.,Noel,D.,andDjouad,F.(2015)Gilz governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells. [E-pub ahead of print] Arthritis Rheumatol. 10.1002/art.39069